Acquired factor VIII inhibitor and subsequent development of non-Hodgkin's lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Acquired factor VIII inhibitor and subsequent development of non-Hodgkin's lymphoma

Published:2015-12 Issue:8 Volume:26 Page:967-971
ISSN:0957-5235
Container-title:Blood Coagulation & Fibrinolysis
language:en
Short-container-title:

Author:

Porru Mariagrazia,Mameli Antonella,Cianchetti Elisabetta M.,Musu Mario,Montisci Roberto,Finco Gabriele,Marongiu Francesco

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology,General Medicine

Reference16 articles.

1. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors Organisation.;Collins;Blood,2007

2. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).;Knoebl;J Thromb Haemost,2012

3. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A.;Huth-Kuhne;Haematologica,2009

4. Successful use of recombinant FVIIa (Novoseven) in the management of uncontrolled bleeding after emergency fasciotomy.;Sipahi;Haemophilia,2008

5. Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.;Geetha;J Am Soc Nephrol Epub,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Insidious Case of Severe Acquired Factor VIII Inhibitor;Cureus;2023-11-07

2. Unusual complications in the management of chronic lymphocytic leukemia;American Journal of Hematology;2022-05-12

3. Management of autoimmune complications in patients with lymphoid cancer;Blood;2021-09-13

4. Safety and Efficacy of Rituximab and Cyclophosphamide in a Case of Resistant Acquired Hemophilia A in Course of Chronic Lymphocytic Leukemia;Cureus;2019-09-12

5. Hemorrhagic pericardial effusion as the debut of acquired hemophilia in a chronic lymphocytic leukemia patient;Medicine;2017-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3